| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 ABCA1 MYH9 DHX58 MYO5A ACSF2 DNAH1 RAD50 ABCA6 SMARCA4 MACF1 DDX53 MORC3 SNRNP200 | 4.07e-06 | 614 | 105 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | GTPase binding | ABCA1 MYO5A SPTBN1 IQGAP1 RANBP17 GCC2 RABGEF1 ARHGEF2 GGA1 IPO11 | 2.02e-05 | 360 | 105 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | 4.98e-05 | 321 | 105 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 ABCA1 DHX58 RAD50 ABCA6 SMARCA4 MACF1 DDX53 MORC3 SNRNP200 | 1.11e-04 | 441 | 105 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | translation elongation factor activity | 1.51e-04 | 20 | 105 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | enzyme activator activity | CASP8AP2 APAF1 LARS1 CASP1 IQGAP1 RAD50 BMP2 STK11 TBC1D4 PSMC3IP VAV3 RASAL2 | 1.72e-04 | 656 | 105 | 12 | GO:0008047 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH3 ABCA1 DHX58 EEF1A1 EEF1A1P5 EEF1A2 RAD50 ABCA6 SMARCA4 MACF1 DDX53 MORC3 SNRNP200 | 2.13e-04 | 775 | 105 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | enzyme regulator activity | CASP8AP2 GBF1 APAF1 LARS1 CASP1 APC CST7 ELMO1 IQGAP1 RAD50 BMP2 STK11 TBC1D4 PSMC3IP RABGEF1 VAV3 ARHGEF2 RASAL2 | 4.05e-04 | 1418 | 105 | 18 | GO:0030234 |
| GeneOntologyMolecularFunction | cadherin binding | 4.25e-04 | 339 | 105 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 ABCA1 DHX58 EEF1A1 EEF1A1P5 EEF1A2 RAD50 ABCA6 SMARCA4 MACF1 DDX53 MORC3 SNRNP200 | 4.56e-04 | 839 | 105 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 ABCA1 DHX58 EEF1A1 EEF1A1P5 EEF1A2 RAD50 ABCA6 SMARCA4 MACF1 DDX53 MORC3 SNRNP200 | 4.61e-04 | 840 | 105 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 ABCA1 DHX58 EEF1A1 EEF1A1P5 EEF1A2 RAD50 ABCA6 SMARCA4 MACF1 DDX53 MORC3 SNRNP200 | 4.61e-04 | 840 | 105 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activator activity involved in apoptotic process | 4.67e-04 | 29 | 105 | 3 | GO:0008656 | |
| GeneOntologyMolecularFunction | peptidase activator activity involved in apoptotic process | 6.27e-04 | 32 | 105 | 3 | GO:0016505 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.42e-03 | 507 | 105 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.42e-03 | 507 | 105 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | helicase activity | 1.49e-03 | 158 | 105 | 5 | GO:0004386 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 5.88e-06 | 89 | 104 | 6 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.15e-05 | 100 | 104 | 6 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.53e-05 | 105 | 104 | 6 | GO:1901879 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MYH9 GBF1 MYO5A EML4 APC MILR1 STK11 C17orf75 CADPS RABGEF1 ARHGEF2 CADPS2 | 1.98e-05 | 546 | 104 | 12 | GO:0051656 |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 3.11e-05 | 119 | 104 | 6 | GO:0006892 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 3.95e-05 | 38 | 104 | 4 | GO:0007026 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 5.89e-05 | 42 | 104 | 4 | GO:0031114 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane protein transport | 7.75e-05 | 45 | 104 | 4 | GO:0043001 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 9.02e-05 | 144 | 104 | 6 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 9.02e-05 | 144 | 104 | 6 | GO:0043244 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 1.27e-04 | 51 | 104 | 4 | GO:0031111 | |
| GeneOntologyBiologicalProcess | negative regulation of organ growth | 1.48e-04 | 53 | 104 | 4 | GO:0046621 | |
| GeneOntologyBiologicalProcess | organelle localization | MYH9 GBF1 MYO5A EML4 APC MILR1 STK11 C17orf75 CADPS RABGEF1 ARHGEF2 CADPS2 | 2.20e-04 | 703 | 104 | 12 | GO:0051640 |
| GeneOntologyCellularComponent | ruffle | 9.24e-05 | 206 | 107 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 1.55e-04 | 4 | 107 | 2 | GO:0005853 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 5.32e-04 | 129 | 107 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | cell cortex | 6.46e-04 | 371 | 107 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH9 MYO5A INPP5D SPTBN1 ANKRD26 IQGAP1 EEF1A1 BAIAP2L1 MACF1 ARHGEF2 | 7.48e-04 | 576 | 107 | 10 | GO:0015629 |
| GeneOntologyCellularComponent | supramolecular fiber | DNAH3 MYH9 MYO5A EML4 INPP5D SPTBN1 CASP1 APC TRIM54 IQGAP1 DNAH1 STK11 MACF1 ARHGEF2 MYBPC2 | 9.73e-04 | 1179 | 107 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | DNAH3 MYH9 MYO5A EML4 INPP5D SPTBN1 CASP1 APC TRIM54 IQGAP1 DNAH1 STK11 MACF1 ARHGEF2 MYBPC2 | 1.04e-03 | 1187 | 107 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | cell leading edge | 1.08e-03 | 500 | 107 | 9 | GO:0031252 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.14e-03 | 10 | 107 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.34e-03 | 93 | 107 | 4 | GO:0030864 | |
| Domain | P-loop_NTPase | ADCY10 DNAH3 ABCA1 MYH9 DHX58 MYO5A APAF1 IQGAP1 EEF1A1 DNAH1 EEF1A2 RAD50 TRANK1 ABCA6 SMARCA4 DDX53 SNRNP200 | 4.22e-06 | 848 | 104 | 17 | IPR027417 |
| Domain | CAPS | 3.07e-05 | 2 | 104 | 2 | IPR033227 | |
| Domain | Transl_elong_EF1A_euk/arc | 3.07e-05 | 2 | 104 | 2 | IPR004539 | |
| Domain | C2_dom | 3.68e-05 | 164 | 104 | 7 | IPR000008 | |
| Domain | - | ADCY10 DNAH3 ABCA1 DHX58 APAF1 EEF1A1 DNAH1 EEF1A2 RAD50 TRANK1 ABCA6 SMARCA4 DDX53 SNRNP200 | 6.62e-05 | 746 | 104 | 14 | 3.40.50.300 |
| Domain | C2 | 1.43e-04 | 142 | 104 | 6 | PS50004 | |
| Domain | PH | 1.63e-04 | 278 | 104 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 1.67e-04 | 279 | 104 | 8 | PS50003 | |
| Domain | PH_domain | 1.72e-04 | 280 | 104 | 8 | IPR001849 | |
| Domain | DUF1041 | 3.04e-04 | 5 | 104 | 2 | SM01145 | |
| Domain | - | 3.36e-04 | 391 | 104 | 9 | 2.30.29.30 | |
| Domain | PH_12 | 4.54e-04 | 6 | 104 | 2 | PF16457 | |
| Domain | CH | 4.73e-04 | 65 | 104 | 4 | SM00033 | |
| Domain | PH_dom-like | 6.24e-04 | 426 | 104 | 9 | IPR011993 | |
| Domain | CH | 6.27e-04 | 70 | 104 | 4 | PF00307 | |
| Domain | Munc13_1 | 6.33e-04 | 7 | 104 | 2 | IPR014770 | |
| Domain | MHD1 | 6.33e-04 | 7 | 104 | 2 | PS51258 | |
| Domain | DUF1041 | 6.33e-04 | 7 | 104 | 2 | PF06292 | |
| Domain | CAPS_dom | 6.33e-04 | 7 | 104 | 2 | IPR010439 | |
| Domain | - | 6.62e-04 | 71 | 104 | 4 | 1.10.418.10 | |
| Domain | CH | 7.35e-04 | 73 | 104 | 4 | PS50021 | |
| Domain | CH-domain | 8.14e-04 | 75 | 104 | 4 | IPR001715 | |
| Domain | Transl_elong_EFTu/EF1A_C | 8.41e-04 | 8 | 104 | 2 | IPR004160 | |
| Domain | GTP_EFTU_D3 | 8.41e-04 | 8 | 104 | 2 | PF03143 | |
| Domain | G_TR_CS | 1.08e-03 | 9 | 104 | 2 | IPR031157 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 1.34e-03 | 10 | 104 | 2 | IPR009001 | |
| Domain | - | 1.43e-03 | 148 | 104 | 5 | 2.60.40.150 | |
| Domain | - | 1.52e-03 | 222 | 104 | 6 | 1.25.10.10 | |
| Domain | PH | 1.78e-03 | 229 | 104 | 6 | PF00169 | |
| Domain | ABC_A | 1.95e-03 | 12 | 104 | 2 | IPR026082 | |
| Domain | G_TR_1 | 2.30e-03 | 13 | 104 | 2 | PS00301 | |
| Domain | RasGAP | 2.68e-03 | 14 | 104 | 2 | SM00323 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.68e-03 | 14 | 104 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.68e-03 | 14 | 104 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.68e-03 | 14 | 104 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.68e-03 | 14 | 104 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.68e-03 | 14 | 104 | 2 | IPR011704 | |
| Domain | MT | 2.68e-03 | 14 | 104 | 2 | PF12777 | |
| Domain | AAA_8 | 2.68e-03 | 14 | 104 | 2 | PF12780 | |
| Domain | RasGAP_CS | 2.68e-03 | 14 | 104 | 2 | IPR023152 | |
| Domain | AAA_5 | 2.68e-03 | 14 | 104 | 2 | PF07728 | |
| Domain | ARM-type_fold | 2.88e-03 | 339 | 104 | 7 | IPR016024 | |
| Domain | Helicase_C | 3.02e-03 | 107 | 104 | 4 | PF00271 | |
| Domain | HELICc | 3.02e-03 | 107 | 104 | 4 | SM00490 | |
| Domain | DHC_fam | 3.08e-03 | 15 | 104 | 2 | IPR026983 | |
| Domain | RasGAP | 3.08e-03 | 15 | 104 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 3.08e-03 | 15 | 104 | 2 | PS00509 | |
| Domain | Dynein_heavy | 3.08e-03 | 15 | 104 | 2 | PF03028 | |
| Domain | IBN_N | 3.08e-03 | 15 | 104 | 2 | PF03810 | |
| Domain | RAS_GTPASE_ACTIV_2 | 3.08e-03 | 15 | 104 | 2 | PS50018 | |
| Domain | Dynein_heavy_dom | 3.08e-03 | 15 | 104 | 2 | IPR004273 | |
| Domain | Helicase_C | 3.12e-03 | 108 | 104 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 3.23e-03 | 109 | 104 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.23e-03 | 109 | 104 | 4 | PS51192 | |
| Domain | DEXDc | 3.23e-03 | 109 | 104 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.33e-03 | 110 | 104 | 4 | IPR014001 | |
| Domain | IBN_N | 3.50e-03 | 16 | 104 | 2 | SM00913 | |
| Domain | - | 3.50e-03 | 16 | 104 | 2 | 1.10.506.10 | |
| Domain | Importin-beta_N | 3.95e-03 | 17 | 104 | 2 | IPR001494 | |
| Domain | ARM-like | 4.02e-03 | 270 | 104 | 6 | IPR011989 | |
| Domain | RUN | 4.43e-03 | 18 | 104 | 2 | SM00593 | |
| Domain | EFTu-like_2 | 4.43e-03 | 18 | 104 | 2 | IPR004161 | |
| Domain | RasGAP_dom | 4.43e-03 | 18 | 104 | 2 | IPR001936 | |
| Domain | GTP_EFTU_D2 | 4.43e-03 | 18 | 104 | 2 | PF03144 | |
| Domain | G_TR_2 | 4.43e-03 | 18 | 104 | 2 | PS51722 | |
| Domain | RUN | 4.94e-03 | 19 | 104 | 2 | PS50826 | |
| Domain | TF_GTP-bd_dom | 4.94e-03 | 19 | 104 | 2 | IPR000795 | |
| Domain | Myosin-like_IQ_dom | 4.94e-03 | 19 | 104 | 2 | IPR027401 | |
| Domain | - | 4.94e-03 | 19 | 104 | 2 | 4.10.270.10 | |
| Domain | RUN | 4.94e-03 | 19 | 104 | 2 | PF02759 | |
| Domain | Run_dom | 4.94e-03 | 19 | 104 | 2 | IPR004012 | |
| Pubmed | PTGES2 HIVEP2 MYO5A IFT74 SPTBN1 PSMB4 LARS1 APC REV3L IQGAP1 STAT6 EEF1A1 EEF1A2 RUFY2 CADPS SMARCA4 LRRCC1 MACF1 MORC3 CADPS2 PC SNRNP200 GOLGA3 RASAL2 LRRFIP1 | 1.41e-13 | 1285 | 108 | 25 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP2 GBF1 DSC2 OFD1 IFT74 SPTBN1 ANKRD26 APC EEF1A1 EEF1A2 WWC2 TBC1D4 BAIAP2L1 MACF1 RABGEF1 MPHOSPH9 MORC3 ARHGEF2 PC MAP2K7 RASAL2 | 2.36e-13 | 861 | 108 | 21 | 36931259 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | OFD1 IFT74 ANKRD26 APC CFI IQGAP1 RAD50 BAIAP2L1 LRRCC1 MPHOSPH9 MORC3 ARHGEF2 PC GGA1 FHIP2B | 6.52e-08 | 853 | 108 | 15 | 28718761 |
| Pubmed | MYH9 MYO5A SPTBN1 LARS1 APC ALG2 IQGAP1 EEF1A1 EEF1A2 CADPS SMARCA4 LRRCC1 MACF1 ARHGEF2 PC SNRNP200 GOLGA3 RASAL2 LRRFIP1 | 8.44e-08 | 1431 | 108 | 19 | 37142655 | |
| Pubmed | GBF1 SPTBN1 EEF1A1 TBC1D4 BAIAP2L1 RABGEF1 ARHGEF2 SNRNP200 RASAL2 | 1.11e-07 | 255 | 108 | 9 | 15324660 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.41e-07 | 202 | 108 | 8 | 33005030 | |
| Pubmed | 2.41e-07 | 202 | 108 | 8 | 24639526 | ||
| Pubmed | MYH9 MYO5A SPTBN1 APC IQGAP1 EEF1A1 EEF1A2 RAD50 SMARCA4 MACF1 RABGEF1 ARHGEF2 GOLGA3 RASAL2 LRRFIP1 | 3.08e-07 | 963 | 108 | 15 | 28671696 | |
| Pubmed | 3.13e-07 | 209 | 108 | 8 | 36779422 | ||
| Pubmed | 4.10e-07 | 20 | 108 | 4 | 21689717 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | MYH9 IFT74 APAF1 LARS1 EEF1A1 EEF1A2 RAD50 CADPS MACF1 PNPLA8 PHIP | 4.60e-07 | 498 | 108 | 11 | 36634849 |
| Pubmed | 6.03e-07 | 312 | 108 | 9 | 37120454 | ||
| Pubmed | MYH9 DSC2 ANKRD26 APC SLC39A10 BAIAP2L1 GCC2 MPHOSPH9 PC GGA1 SNRNP200 GOLGA3 RASAL2 | 9.17e-07 | 777 | 108 | 13 | 35844135 | |
| Pubmed | MYH9 MYO5A SPTBN1 PSMB4 LARS1 IQGAP1 EEF1A2 SNRNP200 LRRFIP1 | 1.06e-06 | 334 | 108 | 9 | 30425250 | |
| Pubmed | 1.23e-06 | 340 | 108 | 9 | 24332808 | ||
| Pubmed | GBF1 OFD1 ANKRD26 APC TBC1D4 RABGEF1 MPHOSPH9 ARHGEF2 RASAL2 IPO11 | 1.38e-06 | 446 | 108 | 10 | 24255178 | |
| Pubmed | MYH9 SPTBN1 LARS1 APC AXIN2 IQGAP1 EEF1A1 EEF1A2 C17orf75 BAIAP2L1 ARHGEF2 SNRNP200 LRRFIP1 | 1.43e-06 | 809 | 108 | 13 | 32129710 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH9 EML4 SPTBN1 LARS1 IQGAP1 EEF1A1 EEF1A1P5 RAD50 TBC1D4 BAIAP2L1 NIP7 SMARCA4 MACF1 ARHGEF2 PC SNRNP200 LRRFIP1 | 1.73e-06 | 1415 | 108 | 17 | 28515276 |
| Pubmed | 1.96e-06 | 360 | 108 | 9 | 33111431 | ||
| Pubmed | MYH9 DSC2 SPTBN1 LARS1 ANKRD26 APC IQGAP1 BAIAP2L1 MACF1 MPHOSPH9 SNRNP200 RASAL2 | 2.17e-06 | 708 | 108 | 12 | 39231216 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH9 GBF1 EML4 LARS1 APOD IQGAP1 EEF1A2 RAD50 CCDC59 TBC1D4 SMARCA4 RABGEF1 ARHGEF2 SNRNP200 RASAL2 IPO11 | 2.26e-06 | 1284 | 108 | 16 | 17353931 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH9 ATR IFT74 SPTBN1 LARS1 IQGAP1 EEF1A1 EEF1A1P5 SNRNP200 LRRFIP1 | 2.50e-06 | 477 | 108 | 10 | 31300519 |
| Pubmed | 2.52e-06 | 69 | 108 | 5 | 32238831 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GBF1 IFT74 PSMB4 LARS1 APOD REV3L RAD50 CCDC59 TBC1D4 SUDS3 SMARCA4 ARHGEF2 SNRNP200 | 2.69e-06 | 857 | 108 | 13 | 25609649 |
| Pubmed | USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. | 3.44e-06 | 10 | 108 | 3 | 36653359 | |
| Pubmed | 3.54e-06 | 496 | 108 | 10 | 31343991 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 MYO5A EML4 SPTBN1 PSMB4 LARS1 IQGAP1 RAD50 TBC1D4 SMARCA4 MACF1 ARHGEF2 IL36G SNRNP200 PHIP RASAL2 | 4.41e-06 | 1353 | 108 | 16 | 29467282 |
| Pubmed | GBF1 EML4 SPTBN1 LARS1 IQGAP1 RAD50 TBC1D4 SMARCA4 MAP2K7 SNRNP200 IPO11 | 5.02e-06 | 638 | 108 | 11 | 33239621 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GBF1 ATR EML4 SPTBN1 IQGAP1 RAD50 WWC2 TBC1D4 SMARCA4 ARHGEF2 SNRNP200 LRRFIP1 | 5.37e-06 | 774 | 108 | 12 | 15302935 |
| Pubmed | 6.58e-06 | 418 | 108 | 9 | 34709266 | ||
| Pubmed | 6.91e-06 | 147 | 108 | 6 | 16959763 | ||
| Pubmed | 6.92e-06 | 225 | 108 | 7 | 12168954 | ||
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 7.08e-06 | 85 | 108 | 5 | 16051665 | |
| Pubmed | MYH9 SPTBN1 PSMB4 LARS1 IQGAP1 EEF1A1P5 EEF1A2 TBC1D4 MACF1 SNRNP200 | 7.21e-06 | 538 | 108 | 10 | 28524877 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH9 MYO5A SPTBN1 LARS1 IQGAP1 EEF1A1 EEF1A1P5 CCDC59 SMARCA4 ARHGEF2 PC SNRNP200 LRRFIP1 | 8.08e-06 | 949 | 108 | 13 | 36574265 |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18177725 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21262765 | ||
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 9.55e-06 | 2 | 108 | 2 | 30782564 | |
| Pubmed | APC:T1556fs and STK11 mutations in duodenal adenomas and adenocarcinomas. | 9.55e-06 | 2 | 108 | 2 | 29525853 | |
| Pubmed | Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. | 9.55e-06 | 2 | 108 | 2 | 21982234 | |
| Pubmed | CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins. | 9.55e-06 | 2 | 108 | 2 | 18022372 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29545013 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28075014 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 35741005 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28883501 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11809809 | ||
| Pubmed | The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. | 9.55e-06 | 2 | 108 | 2 | 30370994 | |
| Pubmed | Two distinct secretory vesicle-priming steps in adrenal chromaffin cells. | 9.55e-06 | 2 | 108 | 2 | 20855507 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26212729 | ||
| Pubmed | CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles. | 9.55e-06 | 2 | 108 | 2 | 18495893 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17825975 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28654863 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22095224 | ||
| Pubmed | BMP-2 regulates the expression of myosin Va via smad in melan-a melanocyte. | 9.55e-06 | 2 | 108 | 2 | 38787453 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 38220433 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19636410 | ||
| Pubmed | LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. | 9.55e-06 | 2 | 108 | 2 | 11445556 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25719439 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37594641 | ||
| Pubmed | Regulation of T helper type 2 cell differentiation by murine Schnurri-2. | 9.55e-06 | 2 | 108 | 2 | 15699073 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 7945283 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32347192 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 9.75e-06 | 332 | 108 | 8 | 32786267 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 9.96e-06 | 333 | 108 | 8 | 32665550 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.26e-05 | 344 | 108 | 8 | 30333137 | |
| Pubmed | 1.29e-05 | 15 | 108 | 3 | 8812466 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | MYH9 ATR SPTBN1 IQGAP1 RAD50 SMARCA4 MACF1 ARHGEF2 MAP2K7 SNRNP200 | 1.42e-05 | 582 | 108 | 10 | 20467437 |
| Pubmed | CASP8AP2 DSC2 OFD1 MYO5A SPTBN1 APAF1 ANKRD26 SLC39A10 SNX29 EEF1A2 NIP7 MACF1 PNPLA8 SNRNP200 GOLGA3 RASAL2 | 1.43e-05 | 1487 | 108 | 16 | 33957083 | |
| Pubmed | MYH9 GBF1 OFD1 MYO5A EML4 ALG2 ELMO1 EEF1A1 RAD50 GCC2 SMARCA4 MPHOSPH9 GGA1 GOLGA3 | 1.59e-05 | 1168 | 108 | 14 | 19946888 | |
| Pubmed | Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. | 1.90e-05 | 263 | 108 | 7 | 19773279 | |
| Pubmed | CASP8AP2 MYH9 HIVEP2 SPTBN1 APC MACF1 VAV3 MPHOSPH9 SNRNP200 | 2.17e-05 | 486 | 108 | 9 | 20936779 | |
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 2.29e-05 | 374 | 108 | 8 | 19625176 | |
| Pubmed | Genome-wide association analysis identifies 13 new risk loci for schizophrenia. | 2.38e-05 | 109 | 108 | 5 | 23974872 | |
| Pubmed | GBF1 ANKRD26 RUFY2 ZNF665 LRRCC1 MACF1 ZNF518B MORC3 SNRNP200 | 2.43e-05 | 493 | 108 | 9 | 15368895 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | GBF1 ATR EML4 ACSF2 STAT6 EEF1A2 RUFY2 SLC16A6 ZNRF3 MACF1 ARHGEF2 PC IPO11 | 2.61e-05 | 1061 | 108 | 13 | 33845483 |
| Pubmed | 2.62e-05 | 381 | 108 | 8 | 18676680 | ||
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 2.67e-05 | 382 | 108 | 8 | 19170196 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26073433 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 15565649 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 19559761 | ||
| Pubmed | Secretory vesicle priming by CAPS is independent of its SNARE-binding MUN domain. | 2.86e-05 | 3 | 108 | 2 | 25437547 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 37429391 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12659812 | ||
| Pubmed | An Alternative Exon of CAPS2 Influences Catecholamine Loading into LDCVs of Chromaffin Cells. | 2.86e-05 | 3 | 108 | 2 | 30389842 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 35493485 | ||
| Pubmed | IPO11 mediates βcatenin nuclear import in a subset of colorectal cancers. | 2.86e-05 | 3 | 108 | 2 | 31881079 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 38970714 | ||
| Pubmed | Ca2+-dependent activator proteins of secretion promote vesicular monoamine uptake. | 2.86e-05 | 3 | 108 | 2 | 19008227 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 25599959 | ||
| Pubmed | Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma. | 2.86e-05 | 3 | 108 | 2 | 18384130 | |
| Pubmed | Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells. | 2.86e-05 | 3 | 108 | 2 | 23393221 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 14530279 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 18448518 | ||
| Pubmed | Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. | 2.86e-05 | 3 | 108 | 2 | 18846228 | |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 2.96e-05 | 190 | 108 | 6 | 15161933 | |
| Pubmed | 3.06e-05 | 57 | 108 | 4 | 29089450 | ||
| Pubmed | REV3L C17orf75 CCDC59 ADAMTS6 ZNF665 GCC2 SUGP1 ARHGEF2 RASAL2 FHIP2B | 3.11e-05 | 638 | 108 | 10 | 31182584 | |
| Pubmed | 3.28e-05 | 58 | 108 | 4 | 19013454 | ||
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 3.48e-05 | 118 | 108 | 5 | 27377895 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH9 MYO5A SPTBN1 LARS1 IQGAP1 EEF1A1 RAD50 BAIAP2L1 NIP7 SMARCA4 ARHGEF2 SNRNP200 RASAL2 LRRFIP1 | 3.56e-05 | 1257 | 108 | 14 | 36526897 |
| Interaction | KXD1 interactions | EML4 IFT74 SNX29 GCC2 PSMC3IP RABGEF1 MPHOSPH9 CCDC136 GOLGA3 | 3.09e-07 | 170 | 107 | 9 | int:KXD1 |
| Interaction | GOLGA1 interactions | 5.75e-07 | 183 | 107 | 9 | int:GOLGA1 | |
| Interaction | YWHAH interactions | HIVEP2 GBF1 DSC2 OFD1 IFT74 SPTBN1 ANKRD26 APC IQGAP1 EEF1A1 EEF1A2 WWC2 TBC1D4 BAIAP2L1 MACF1 RABGEF1 MPHOSPH9 MORC3 ARHGEF2 RASAL2 | 1.22e-06 | 1102 | 107 | 20 | int:YWHAH |
| Interaction | RCOR1 interactions | CASP8AP2 MYH9 EML4 IFT74 APC RAD50 GCC2 SMARCA4 RABGEF1 PC PHIP GOLGA3 LRRFIP1 | 2.19e-06 | 494 | 107 | 13 | int:RCOR1 |
| Interaction | TMOD1 interactions | 2.32e-06 | 161 | 107 | 8 | int:TMOD1 | |
| Interaction | DYNLL1 interactions | MYH9 OFD1 MYO5A EML4 LARS1 TRIM54 EEF1A1 RAD50 WWC2 MPHOSPH9 MORC3 PC CCDC136 | 3.11e-06 | 510 | 107 | 13 | int:DYNLL1 |
| Interaction | PKNOX1 interactions | 4.91e-06 | 82 | 107 | 6 | int:PKNOX1 | |
| Interaction | FER1L6 interactions | 5.01e-06 | 7 | 107 | 3 | int:FER1L6 | |
| Interaction | YWHAB interactions | GBF1 DSC2 SPTBN1 ANKRD26 APC IQGAP1 RAD50 WWC2 TBC1D4 BAIAP2L1 GCC2 MACF1 RABGEF1 MPHOSPH9 MORC3 ARHGEF2 SNRNP200 RASAL2 | 6.12e-06 | 1014 | 107 | 18 | int:YWHAB |
| Interaction | RAB11A interactions | MYH9 GBF1 DSC2 ATR MYO5A SPTBN1 PSMB4 ANKRD26 SLC39A10 BAIAP2L1 GCC2 NIP7 RABGEF1 GOLGA3 RASAL2 LRRFIP1 | 7.71e-06 | 830 | 107 | 16 | int:RAB11A |
| Interaction | YWHAG interactions | HIVEP2 GBF1 DSC2 SPTBN1 ANKRD26 APC IQGAP1 EEF1A1 STK11 WWC2 TBC1D4 BAIAP2L1 GCC2 MACF1 RABGEF1 MPHOSPH9 MORC3 ARHGEF2 SNRNP200 RASAL2 | 8.03e-06 | 1248 | 107 | 20 | int:YWHAG |
| Interaction | EPB41L4A interactions | 9.82e-06 | 140 | 107 | 7 | int:EPB41L4A | |
| Interaction | RAB35 interactions | DSC2 MYO5A SPTBN1 ANKRD26 APC TRIM54 SLC39A10 SNX29 IQGAP1 BAIAP2L1 MACF1 GOLGA3 RASAL2 | 1.09e-05 | 573 | 107 | 13 | int:RAB35 |
| Interaction | LRRC31 interactions | 1.38e-05 | 205 | 107 | 8 | int:LRRC31 | |
| Interaction | KCNA3 interactions | ADCY10 MYH9 DSC2 SPTBN1 LARS1 ANKRD26 APC IQGAP1 RAD50 TBC1D4 BAIAP2L1 SMARCA4 MACF1 MPHOSPH9 SNRNP200 RASAL2 | 1.40e-05 | 871 | 107 | 16 | int:KCNA3 |
| Interaction | YWHAZ interactions | MYH9 HIVEP2 GBF1 DSC2 MYO5A SPTBN1 ANKRD26 APC EEF1A1 WWC2 TBC1D4 BAIAP2L1 GCC2 MACF1 RABGEF1 MPHOSPH9 MORC3 ARHGEF2 GOLGA3 RASAL2 | 1.80e-05 | 1319 | 107 | 20 | int:YWHAZ |
| Interaction | GPS1 interactions | 2.15e-05 | 218 | 107 | 8 | int:GPS1 | |
| Interaction | SPATA16 interactions | 2.79e-05 | 2 | 107 | 2 | int:SPATA16 | |
| Interaction | YWHAE interactions | HIVEP2 GBF1 DSC2 LARS1 ANKRD26 APC IQGAP1 EEF1A1 EEF1A2 WWC2 TBC1D4 BAIAP2L1 GCC2 MACF1 MPHOSPH9 MORC3 ARHGEF2 GOLGA3 RASAL2 | 3.12e-05 | 1256 | 107 | 19 | int:YWHAE |
| Interaction | DNAJC5 interactions | DSC2 MYO5A SPTBN1 ANKRD26 SLC39A10 CADPS MACF1 RABGEF1 GOLGA3 RASAL2 | 3.34e-05 | 378 | 107 | 10 | int:DNAJC5 |
| Interaction | NDC80 interactions | OFD1 IFT74 ANKRD26 RAD50 GCC2 LRRCC1 MPHOSPH9 CCDC136 GOLGA3 | 4.32e-05 | 312 | 107 | 9 | int:NDC80 |
| Interaction | FLOT1 interactions | ABCA1 MYH9 DSC2 OFD1 SPTBN1 ANKRD26 APC SLC39A10 IQGAP1 MACF1 RASAL2 | 4.50e-05 | 475 | 107 | 11 | int:FLOT1 |
| Interaction | RAB2A interactions | GBF1 DSC2 OFD1 MYO5A SPTBN1 SLC39A10 IQGAP1 EEF1A1 GCC2 RABGEF1 GOLGA3 RASAL2 | 4.78e-05 | 567 | 107 | 12 | int:RAB2A |
| Interaction | USP14 interactions | MYH9 GBF1 MYO5A SPTBN1 PSMB4 LARS1 IQGAP1 EEF1A2 MACF1 SNRNP200 LRRFIP1 | 5.84e-05 | 489 | 107 | 11 | int:USP14 |
| Interaction | SYCE1 interactions | 5.98e-05 | 127 | 107 | 6 | int:SYCE1 | |
| Interaction | GJA1 interactions | GBF1 DSC2 SPTBN1 ANKRD26 APC SLC39A10 EEF1A1 EEF1A2 GCC2 MACF1 GOLGA3 RASAL2 | 6.24e-05 | 583 | 107 | 12 | int:GJA1 |
| Interaction | PINK1 interactions | MYH9 DSC2 ATR IFT74 SPTBN1 LARS1 IQGAP1 EEF1A1 EEF1A1P5 PC IL36G SNRNP200 LRRFIP1 | 6.35e-05 | 679 | 107 | 13 | int:PINK1 |
| Interaction | DCTN1 interactions | GBF1 OFD1 EML4 IFT74 SPTBN1 APC EEF1A1 MACF1 MPHOSPH9 ARHGEF2 LRRFIP1 | 6.75e-05 | 497 | 107 | 11 | int:DCTN1 |
| Interaction | VARS1 interactions | 7.47e-05 | 260 | 107 | 8 | int:VARS1 | |
| Interaction | SFN interactions | GBF1 DSC2 SPTBN1 ANKRD26 APC EEF1A1 WWC2 TBC1D4 MACF1 RABGEF1 MPHOSPH9 ARHGEF2 RASAL2 | 7.69e-05 | 692 | 107 | 13 | int:SFN |
| Interaction | LGR4 interactions | 7.88e-05 | 262 | 107 | 8 | int:LGR4 | |
| Interaction | DIRAS3 interactions | 7.88e-05 | 262 | 107 | 8 | int:DIRAS3 | |
| Interaction | DYNLL2 interactions | 8.09e-05 | 263 | 107 | 8 | int:DYNLL2 | |
| Interaction | PFN1 interactions | MYH9 MYO5A IFT74 SPTBN1 ANKRD26 APC EEF1A2 BAIAP2L1 GCC2 MACF1 GOLGA3 | 8.35e-05 | 509 | 107 | 11 | int:PFN1 |
| Interaction | PHF21A interactions | 8.95e-05 | 343 | 107 | 9 | int:PHF21A | |
| Interaction | RHOG interactions | DSC2 SPCS1 SPTBN1 APAF1 ANKRD26 SLC39A10 ELMO1 IQGAP1 EEF1A2 BAIAP2L1 MACF1 PNPLA8 VAV3 RASAL2 IPO11 | 9.15e-05 | 910 | 107 | 15 | int:RHOG |
| Interaction | ADARB2 interactions | 9.37e-05 | 17 | 107 | 3 | int:ADARB2 | |
| Interaction | KIF5B interactions | 9.99e-05 | 348 | 107 | 9 | int:KIF5B | |
| Interaction | LAMTOR1 interactions | DSC2 MYO5A SPTBN1 SLC39A10 SNX29 ALG2 IQGAP1 EEF1A1 RUFY2 STK11 GCC2 GOLGA3 RASAL2 | 1.17e-04 | 722 | 107 | 13 | int:LAMTOR1 |
| Interaction | SEPTIN10 interactions | 1.20e-04 | 144 | 107 | 6 | int:SEPTIN10 | |
| Interaction | KRT8 interactions | MYH9 OFD1 IFT74 CASP1 ANKRD26 APC TRIM54 TBC1D4 MPHOSPH9 GOLGA3 | 1.21e-04 | 441 | 107 | 10 | int:KRT8 |
| Interaction | KCTD13 interactions | MYH9 MYO5A SPTBN1 LARS1 APC ALG2 IQGAP1 EEF1A1 EEF1A2 CADPS SMARCA4 LRRCC1 MACF1 ARHGEF2 PC SNRNP200 GOLGA3 RASAL2 LRRFIP1 | 1.26e-04 | 1394 | 107 | 19 | int:KCTD13 |
| Interaction | ATG16L1 interactions | WWC3 OFD1 MYO5A EML4 INPP5D LARS1 APC SNX29 ELMO1 BAIAP2L1 GCC2 SUGP1 ARHGEF2 MAP2K7 GOLGA3 IPO11 PDZD4 | 1.28e-04 | 1161 | 107 | 17 | int:ATG16L1 |
| Interaction | STX6 interactions | GBF1 DSC2 SPTBN1 ANKRD26 SLC39A10 ABCA6 GCC2 MACF1 GOLGA3 RASAL2 | 1.37e-04 | 448 | 107 | 10 | int:STX6 |
| Interaction | USP15 interactions | MYH9 GBF1 EML4 PSMB4 APC TRIM54 IQGAP1 EEF1A1 RABGEF1 GOLGA3 LRRFIP1 | 1.55e-04 | 546 | 107 | 11 | int:USP15 |
| Interaction | TRAF3IP1 interactions | 1.60e-04 | 96 | 107 | 5 | int:TRAF3IP1 | |
| Interaction | USP4 interactions | 1.70e-04 | 293 | 107 | 8 | int:USP4 | |
| Interaction | CEP128 interactions | 1.87e-04 | 297 | 107 | 8 | int:CEP128 | |
| Interaction | PEX5L interactions | 1.94e-04 | 54 | 107 | 4 | int:PEX5L | |
| Interaction | GSK3B interactions | MYH9 OFD1 APC SNX29 AXIN2 IQGAP1 EEF1A1 STK11 TBC1D4 BAIAP2L1 MACF1 MAP2K7 GOLGA3 RASAL2 | 2.00e-04 | 868 | 107 | 14 | int:GSK3B |
| Interaction | RHOF interactions | GBF1 DSC2 ATR MYO5A SPCS1 SPTBN1 ANKRD26 SLC39A10 IQGAP1 BAIAP2L1 MACF1 RASAL2 | 2.39e-04 | 673 | 107 | 12 | int:RHOF |
| Interaction | HDAC1 interactions | CASP8AP2 MYH9 ATR EML4 IFT74 APC IQGAP1 EEF1A2 RAD50 TBC1D4 SUDS3 GCC2 SMARCA4 PC GOLGA3 LRRFIP1 | 2.41e-04 | 1108 | 107 | 16 | int:HDAC1 |
| Interaction | ANAPC2 interactions | 2.53e-04 | 234 | 107 | 7 | int:ANAPC2 | |
| Interaction | C11orf52 interactions | 2.55e-04 | 311 | 107 | 8 | int:C11orf52 | |
| Interaction | YWHAQ interactions | MYH9 HIVEP2 GBF1 DSC2 ANKRD26 APC IQGAP1 EEF1A1 WWC2 TBC1D4 MACF1 RABGEF1 MPHOSPH9 ARHGEF2 PC RASAL2 | 2.67e-04 | 1118 | 107 | 16 | int:YWHAQ |
| Interaction | USP18 interactions | 2.91e-04 | 60 | 107 | 4 | int:USP18 | |
| Interaction | ITGB3 interactions | 2.95e-04 | 170 | 107 | 6 | int:ITGB3 | |
| Interaction | DSCAM interactions | 3.04e-04 | 171 | 107 | 6 | int:DSCAM | |
| Interaction | SUMO2 interactions | CASP8AP2 SPTBN1 LARS1 IQGAP1 EEF1A1 EEF1A2 RAD50 SMARCA4 MORC3 CCNB1IP1 SNRNP200 | 3.06e-04 | 591 | 107 | 11 | int:SUMO2 |
| Interaction | RHOV interactions | 3.19e-04 | 243 | 107 | 7 | int:RHOV | |
| Interaction | PPP1R12A interactions | 3.22e-04 | 322 | 107 | 8 | int:PPP1R12A | |
| Interaction | HOXB5 interactions | 3.28e-04 | 112 | 107 | 5 | int:HOXB5 | |
| Interaction | COPS3 interactions | 3.35e-04 | 245 | 107 | 7 | int:COPS3 | |
| Interaction | RND1 interactions | 3.43e-04 | 246 | 107 | 7 | int:RND1 | |
| Interaction | AFDN interactions | 4.03e-04 | 333 | 107 | 8 | int:AFDN | |
| Interaction | PXN interactions | 4.11e-04 | 334 | 107 | 8 | int:PXN | |
| Interaction | SNCA interactions | MYH9 IFT74 SPTBN1 APAF1 LARS1 EEF1A1 EEF1A2 RAD50 CADPS MACF1 SNRNP200 PHIP | 4.18e-04 | 716 | 107 | 12 | int:SNCA |
| Interaction | BZW1 interactions | 4.37e-04 | 183 | 107 | 6 | int:BZW1 | |
| Interaction | LYN interactions | MYH9 DSC2 INPP5D SPTBN1 ANKRD26 APC SLC39A10 IQGAP1 BAIAP2L1 MACF1 PHIP RASAL2 | 4.39e-04 | 720 | 107 | 12 | int:LYN |
| Interaction | SYNC interactions | 4.45e-04 | 67 | 107 | 4 | int:SYNC | |
| Interaction | ACTG1 interactions | MYH9 SPTBN1 LARS1 IQGAP1 EEF1A1 EEF1A2 BAIAP2L1 SMARCA4 PNPLA8 LRRFIP1 | 4.50e-04 | 520 | 107 | 10 | int:ACTG1 |
| Interaction | PPP6R3 interactions | 4.56e-04 | 258 | 107 | 7 | int:PPP6R3 | |
| Interaction | H2BC4 interactions | 4.67e-04 | 259 | 107 | 7 | int:H2BC4 | |
| Interaction | RHOQ interactions | DSC2 MYO5A SPTBN1 ANKRD26 SLC39A10 IQGAP1 BAIAP2L1 GOLGA3 RASAL2 | 5.82e-04 | 442 | 107 | 9 | int:RHOQ |
| Interaction | NABP2 interactions | 5.86e-04 | 72 | 107 | 4 | int:NABP2 | |
| Interaction | DCTN2 interactions | 6.26e-04 | 356 | 107 | 8 | int:DCTN2 | |
| Interaction | NR3C1 interactions | CASP8AP2 REV3L EEF1A1P5 C17orf75 CCDC59 ADAMTS6 ZNF665 GCC2 SUGP1 SMARCA4 PSMC3IP ARHGEF2 RASAL2 FHIP2B | 6.38e-04 | 974 | 107 | 14 | int:NR3C1 |
| Interaction | RND3 interactions | 6.38e-04 | 273 | 107 | 7 | int:RND3 | |
| Interaction | ZFPL1 interactions | 6.41e-04 | 448 | 107 | 9 | int:ZFPL1 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.70e-04 | 206 | 72 | 6 | 682 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYH9 HIVEP2 WWC3 ATR OFD1 MYO5A EML4 INPP5D PSMB4 CASP1 CST7 REV3L IQGAP1 EEF1A1 TRANK1 TBC1D4 MACF1 VAV3 SNRNP200 PHIP LRRFIP1 | 4.77e-07 | 1492 | 106 | 21 | M40023 |
| Coexpression | GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN | 1.53e-06 | 199 | 106 | 8 | M3175 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_GC_BCELL_DN | 1.59e-06 | 200 | 106 | 8 | M6385 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 2.89e-06 | 152 | 106 | 7 | M39243 | |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 1.48e-05 | 195 | 106 | 7 | M7382 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 1.69e-05 | 199 | 106 | 7 | M6264 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP | 1.69e-05 | 199 | 106 | 7 | M3478 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN | 1.69e-05 | 199 | 106 | 7 | M3177 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_MESENCHYMAL | 2.86e-05 | 216 | 106 | 7 | M2122 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 4.72e-05 | 97 | 106 | 5 | M14698 | |
| Coexpression | EIF4E_DN | 5.46e-05 | 100 | 106 | 5 | M2790 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | WWC3 SPTBN1 LARS1 APC IQGAP1 EEF1A2 WWC2 SLC16A6 PSMC3IP LRRCC1 MACF1 CADPS2 LRRFIP1 | 6.46e-05 | 892 | 106 | 13 | M18120 |
| Coexpression | GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP | 7.49e-05 | 173 | 106 | 6 | M9425 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | CASP8AP2 WWC3 SPTBN1 CASP1 APOD REV3L IQGAP1 STAT6 SMARCA4 MACF1 MPHOSPH9 LRRFIP1 | 8.52e-05 | 790 | 106 | 12 | M12490 |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_DN | 9.61e-05 | 181 | 106 | 6 | M8187 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | EML4 INPP5D SPTBN1 DNAH1 TBC1D4 MPHOSPH9 MAP2K7 LRRFIP1 IPO11 | 1.34e-04 | 474 | 106 | 9 | M40991 |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP | 1.53e-04 | 378 | 106 | 8 | M34022 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP | 1.57e-04 | 198 | 106 | 6 | M5591 | |
| Coexpression | GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP | 1.61e-04 | 199 | 106 | 6 | M5365 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN | 1.66e-04 | 200 | 106 | 6 | M5986 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP | 1.66e-04 | 200 | 106 | 6 | M6262 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP | 1.66e-04 | 200 | 106 | 6 | M6356 | |
| Coexpression | GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN | 1.66e-04 | 200 | 106 | 6 | M8204 | |
| Coexpression | GSE27786_LIN_NEG_VS_BCELL_DN | 1.66e-04 | 200 | 106 | 6 | M4768 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN | 1.66e-04 | 200 | 106 | 6 | M4968 | |
| Coexpression | GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP | 1.66e-04 | 200 | 106 | 6 | M6790 | |
| Coexpression | GSE10325_MYELOID_VS_LUPUS_MYELOID_DN | 1.66e-04 | 200 | 106 | 6 | M3097 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 1.66e-04 | 200 | 106 | 6 | M4456 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 1.66e-04 | 200 | 106 | 6 | M4449 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_ACTIVATED_T_CELLS | 1.75e-04 | 128 | 106 | 5 | M43603 | |
| Coexpression | DITTMER_PTHLH_TARGETS_DN | 1.89e-04 | 70 | 106 | 4 | M18667 | |
| Coexpression | ZHENG_FOXP3_TARGETS_DN | 2.40e-04 | 6 | 106 | 2 | M1754 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 2.41e-04 | 137 | 106 | 5 | M39241 | |
| Coexpression | KRAS.LUNG_UP.V1_DN | 2.84e-04 | 142 | 106 | 5 | M2893 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 2.89e-04 | 526 | 106 | 9 | M2520 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CASP8AP2 ATR OFD1 EML4 IFT74 INPP5D ANKRD26 APC REV3L SLC39A10 RAD50 RUFY2 RANBP17 ADAMTS6 GCC2 PTCD2 PSMC3IP LRRCC1 PNPLA8 FHIP2B | 2.86e-06 | 1252 | 105 | 20 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CASP8AP2 MYO5A IFT74 ANKRD26 REV3L RAD50 TYW5 GCC2 MPHOSPH9 PHIP | 3.32e-06 | 311 | 105 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | MYH9 DSC2 SPCS1 APAF1 SGPP2 APC REV3L CFI IQGAP1 RUFY2 PLCH2 VAV3 CADPS2 PHIP | 2.76e-05 | 774 | 105 | 14 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CASP8AP2 MYO5A IFT74 ANKRD26 APC REV3L RAD50 RUFY2 RANBP17 CADPS GCC2 PSMC3IP LRRCC1 ZNF518B CADPS2 IL36G PHIP RASAL2 FHIP2B | 3.82e-05 | 1370 | 105 | 19 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.90e-05 | 186 | 105 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CASP8AP2 ATR MYO5A IFT74 ANKRD26 APC REV3L RAD50 RUFY2 GCC2 PSMC3IP LRRCC1 MACF1 ZNF518B IL36G PHIP FHIP2B IPO11 | 4.16e-05 | 1257 | 105 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | ABCA1 MYH9 HIVEP2 INPP5D SPTBN1 APAF1 CASP1 ELMO1 BMP2 MACF1 VAV3 ARHGEF2 RASAL2 LRRFIP1 | 5.97e-05 | 831 | 105 | 14 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CASP8AP2 ATR MYO5A IFT74 SGPP2 ANKRD26 APC REV3L RAD50 RUFY2 GCC2 PSMC3IP LRRCC1 MACF1 ZNF518B IL36G PHIP FHIP2B IPO11 | 8.89e-05 | 1459 | 105 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TRHDE CASP8AP2 MYO5A IFT74 ANKRD26 REV3L RAD50 TYW5 GCC2 PLCH2 SMARCA4 MPHOSPH9 PHIP RASAL2 IPO11 | 1.04e-04 | 989 | 105 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | IFT74 ANKRD26 REV3L RUFY2 EDEM3 C17orf75 ADAMTS6 TYW5 GCC2 MACF1 MPHOSPH9 PHIP GOLGA3 | 1.24e-04 | 780 | 105 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 1.26e-04 | 156 | 105 | 6 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_500 | 1.49e-04 | 394 | 105 | 9 | gudmap_developingKidney_e15.5_Medullary collecting duct_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500 | 1.86e-04 | 406 | 105 | 9 | gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | TRHDE ABCA1 MYO5A APAF1 SGPP2 APC REV3L SLC39A10 RUFY2 C17orf75 CADPS ZNF518B PHIP | 1.99e-04 | 818 | 105 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CASP8AP2 MYO5A IFT74 ANKRD26 APC RAD50 RANBP17 ZNRF3 CADPS GCC2 LRRCC1 MACF1 IL36G RASAL2 FHIP2B | 2.22e-04 | 1060 | 105 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | TRHDE CASP8AP2 MYO5A IFT74 ANKRD26 RAD50 EDEM3 C17orf75 TYW5 MPHOSPH9 PHIP GOLGA3 IPO11 | 2.31e-04 | 831 | 105 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.36e-04 | 330 | 105 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.83e-04 | 339 | 105 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.20e-04 | 261 | 105 | 7 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CASP8AP2 ATR OFD1 IFT74 ANKRD26 APC RAD50 RUFY2 GCC2 LRRCC1 MACF1 PNPLA8 ZNF518B PHIP FHIP2B IPO11 | 3.83e-04 | 1241 | 105 | 16 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.87e-04 | 192 | 105 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.87e-04 | 192 | 105 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 4.09e-04 | 194 | 105 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000 | MYH9 DSC2 SGPP2 APC GCNT1 REV3L IQGAP1 RUFY2 PLCH2 VAV3 CADPS2 LRRFIP1 | 4.96e-04 | 784 | 105 | 12 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.97e-04 | 369 | 105 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | MYH9 DSC2 SGPP2 APC REV3L SNX29 IQGAP1 RUFY2 SLC16A6 PLCH2 VAV3 LRRFIP1 | 5.07e-04 | 786 | 105 | 12 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | ABCA1 MYH9 HIVEP2 INPP5D CASP1 ELMO1 VAV3 ARHGEF2 RASAL2 LRRFIP1 | 5.27e-04 | 570 | 105 | 10 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.52e-04 | 375 | 105 | 8 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | MYH9 SGPP2 APC REV3L CFI IQGAP1 RUFY2 SLC16A6 VAV3 CADPS2 PHIP IPO11 | 6.00e-04 | 801 | 105 | 12 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.12e-04 | 291 | 105 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.04e-04 | 298 | 105 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CASP8AP2 ATR OFD1 ANKRD26 AXIN2 RAD50 RANBP17 TRANK1 SUGP1 MORC3 CCNB1IP1 RASAL2 | 7.36e-04 | 820 | 105 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.71e-06 | 170 | 108 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.83e-06 | 178 | 108 | 6 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 184 | 108 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 185 | 108 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-06 | 187 | 108 | 6 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.60e-06 | 188 | 108 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.23e-06 | 191 | 108 | 6 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.23e-06 | 191 | 108 | 6 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.23e-06 | 191 | 108 | 6 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 7.23e-06 | 191 | 108 | 6 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.23e-06 | 191 | 108 | 6 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-06 | 192 | 108 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.14e-06 | 195 | 108 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 195 | 108 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.62e-06 | 197 | 108 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 9.13e-06 | 199 | 108 | 6 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-MAIT|ICU-SEP / Disease, condition lineage and cell class | 9.13e-06 | 199 | 108 | 6 | 2f10622319c6146dfed8cfe3844180c1e1d56e94 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 9.40e-06 | 200 | 108 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 9.40e-06 | 200 | 108 | 6 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 127 | 108 | 5 | 39fa20a55de3af1a62ab5dfa4877879db3935ac2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.90e-05 | 134 | 108 | 5 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 151 | 108 | 5 | f5ae450e3daa10540ca8437d05efe2d86ac70960 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.70e-05 | 162 | 108 | 5 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 166 | 108 | 5 | 7f8b4cf63c3e292ae421f111edaa4572717f4db1 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 170 | 108 | 5 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 176 | 108 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 7.54e-05 | 179 | 108 | 5 | 5f7e6670a0e906a0a5bc75735408361d88e78fa2 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-05 | 181 | 108 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | a97f052950429245c3231464271e1ba539863bba | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.59e-05 | 184 | 108 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_CD56bright|COVID-19_Mild / Disease group, lineage and cell class | 8.59e-05 | 184 | 108 | 5 | f67308228bb6a5d624279fbb04db25a2f4087c9b | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 8.59e-05 | 184 | 108 | 5 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.81e-05 | 185 | 108 | 5 | 3a046c948524e5d0e986cd645e318d6930d7e0ee | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.81e-05 | 185 | 108 | 5 | 71d1a771026d9fa3528d46ac3d11353e396f2d87 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.81e-05 | 185 | 108 | 5 | 37b48218dd523049b57b13eb9cdb34e106cf91ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.81e-05 | 185 | 108 | 5 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.81e-05 | 185 | 108 | 5 | df5d2309d19ac8d5e429afa785d0a480e75a8f9e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.04e-05 | 186 | 108 | 5 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.04e-05 | 186 | 108 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.50e-05 | 188 | 108 | 5 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 9.74e-05 | 189 | 108 | 5 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 9.74e-05 | 189 | 108 | 5 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.99e-05 | 190 | 108 | 5 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-05 | 190 | 108 | 5 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 191 | 108 | 5 | 51f5af610983aa73b9f4ece6f27d281ebff89a04 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 191 | 108 | 5 | 8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-04 | 191 | 108 | 5 | 82f4a4b0c35638ca4b2c428d0bb946ea95c1001b | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 192 | 108 | 5 | efbd52b3d2b6d3fb9ed6bc3f36aca9f4f1fcbc49 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 193 | 108 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 1.07e-04 | 193 | 108 | 5 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 194 | 108 | 5 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.13e-04 | 195 | 108 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.13e-04 | 195 | 108 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.13e-04 | 195 | 108 | 5 | 0a72b8446399807ace5b6c72f865bb40dbd9e92d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 108 | 5 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 195 | 108 | 5 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 195 | 108 | 5 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 195 | 108 | 5 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | (0)_Myeloid-(010)_cDC|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 1.16e-04 | 196 | 108 | 5 | ea8cf29a9d4d177d092b0568fd4601cd7f906884 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 196 | 108 | 5 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-T_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.18e-04 | 197 | 108 | 5 | 895f18f6a82814653814a698104c59ecbaee5119 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.18e-04 | 197 | 108 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-04 | 197 | 108 | 5 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.18e-04 | 197 | 108 | 5 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.18e-04 | 197 | 108 | 5 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 197 | 108 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.18e-04 | 197 | 108 | 5 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 197 | 108 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | COVID-CD4-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.18e-04 | 197 | 108 | 5 | 39ee4b93625c994813044d8dd8854fba2bd99940 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | cc5ca64749e2f4f1d373d9472824df85741702b7 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | d4d66f19df078bfc3a83d4664aaf9c7789bde1a5 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 1.21e-04 | 198 | 108 | 5 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.21e-04 | 198 | 108 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.24e-04 | 199 | 108 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-04 | 199 | 108 | 5 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.24e-04 | 199 | 108 | 5 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.24e-04 | 199 | 108 | 5 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 199 | 108 | 5 | f4ab29f99ce45a3044d2e9f356dc24d3c5e7121f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 1.27e-04 | 200 | 108 | 5 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 200 | 108 | 5 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | severe-NK_CD56bright|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.27e-04 | 200 | 108 | 5 | 82818ab1796fdd0b8be02b341818897595eed841 | |
| ToppCell | severe-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.27e-04 | 200 | 108 | 5 | 2e67068b98696c313b815a2f0c98643f892e8bc0 | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | GBF1 IFT74 APAF1 ANKRD26 APC RANBP17 STK11 SUGP1 MAP2K7 FHIP2B | 3.17e-08 | 197 | 107 | 10 | 3133_DN |
| Drug | Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 4.11e-06 | 196 | 107 | 8 | 7017_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | 4.43e-06 | 198 | 107 | 8 | 3711_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; HL60; HT_HG-U133A | 4.43e-06 | 198 | 107 | 8 | 3142_DN | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; HL60; HT_HG-U133A | 4.60e-06 | 199 | 107 | 8 | 2933_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; HL60; HG-U133A | 4.60e-06 | 199 | 107 | 8 | 1994_UP | |
| Drug | rimonabant | 3.66e-05 | 265 | 107 | 8 | ctd:C089032 | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; HL60; HT_HG-U133A | 3.72e-05 | 194 | 107 | 7 | 1310_DN | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; PC3; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 1826_UP | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; HL60; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 1332_DN | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HG-U133A | 4.23e-05 | 198 | 107 | 7 | 1907_UP | |
| Drug | Napelline [5008-52-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 4486_UP | |
| Drug | Oxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 4.37e-05 | 199 | 107 | 7 | 3794_UP | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.51e-05 | 200 | 107 | 7 | 3927_UP | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 4.25e-08 | 3 | 104 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | Stomach Carcinoma | 8.32e-07 | 21 | 104 | 4 | C0699791 | |
| Disease | breast cancer (implicated_via_orthology) | 1.74e-06 | 25 | 104 | 4 | DOID:1612 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 7.21e-06 | 200 | 104 | 7 | EFO_0004611, EFO_0020945 | |
| Disease | Benign neoplasm of stomach | 2.79e-05 | 17 | 104 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.79e-05 | 17 | 104 | 3 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.79e-05 | 17 | 104 | 3 | C0154060 | |
| Disease | Stomach Neoplasms | 9.01e-05 | 297 | 104 | 7 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 9.59e-05 | 300 | 104 | 7 | C0024623 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 1.45e-04 | 29 | 104 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 1.61e-04 | 30 | 104 | 3 | C0029925 | |
| Disease | Colorectal Carcinoma | 1.91e-04 | 702 | 104 | 10 | C0009402 | |
| Disease | mean platelet volume | MYH9 HIVEP2 MYO5A PCDHGA5 SPTBN1 ELMO1 EEF1A1P5 TRANK1 TBC1D4 GCC2 PHIP LRRFIP1 | 2.54e-04 | 1020 | 104 | 12 | EFO_0004584 |
| Disease | orofacial cleft (is_implicated_in) | 2.55e-04 | 7 | 104 | 2 | DOID:0050567 (is_implicated_in) | |
| Disease | endometrial cancer (implicated_via_orthology) | 3.40e-04 | 8 | 104 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 3.77e-04 | 96 | 104 | 4 | C1319315 | |
| Disease | cholesterol in very small VLDL measurement | 3.82e-04 | 40 | 104 | 3 | EFO_0022231 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 4.30e-04 | 274 | 104 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.47e-04 | 276 | 104 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | total lipids in very small VLDL measurement | 5.42e-04 | 45 | 104 | 3 | EFO_0022156 | |
| Disease | saturated fatty acids measurement | 5.42e-04 | 45 | 104 | 3 | EFO_0022304 | |
| Disease | eye disease | 5.42e-04 | 45 | 104 | 3 | EFO_0003966 | |
| Disease | free cholesterol in very small VLDL measurement | 6.16e-04 | 47 | 104 | 3 | EFO_0022275 | |
| Disease | colon cancer (implicated_via_orthology) | 6.63e-04 | 11 | 104 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | eosinophil count | DNAH3 HIVEP2 ATR INPP5D SPTBN1 ELMO1 STAT6 EEF1A1P5 RAD50 TBC1D4 SMARCA4 VAV3 MPHOSPH9 SNRNP200 | 7.33e-04 | 1488 | 104 | 14 | EFO_0004842 |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 7.81e-04 | 307 | 104 | 6 | EFO_0004612, EFO_0020946 | |
| Disease | free cholesterol in large LDL measurement | 7.83e-04 | 51 | 104 | 3 | EFO_0022176 | |
| Disease | phospholipids in very small VLDL measurement | 7.83e-04 | 51 | 104 | 3 | EFO_0022300 | |
| Disease | total lipids in LDL measurement | 8.29e-04 | 52 | 104 | 3 | EFO_0022308 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 8.74e-04 | 120 | 104 | 4 | EFO_0004611, EFO_0004639 | |
| Disease | total phospholipids in lipoprotein particles measurement | 8.77e-04 | 53 | 104 | 3 | EFO_0022315 | |
| Disease | alkaline phosphatase measurement | SPTBN1 CFI EDEM3 TRANK1 BAIAP2L1 ABCA6 ZNRF3 GCC2 SUGP1 PTCD2 MACF1 | 9.14e-04 | 1015 | 104 | 11 | EFO_0004533 |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 9.36e-04 | 13 | 104 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Benign tumor of pancreas | 9.36e-04 | 13 | 104 | 2 | C0347284 | |
| Disease | gallbladder cancer (is_implicated_in) | 9.36e-04 | 13 | 104 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | docosahexaenoic acid measurement | 1.08e-03 | 127 | 104 | 4 | EFO_0007761 | |
| Disease | total lipids in large LDL | 1.08e-03 | 57 | 104 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 1.08e-03 | 57 | 104 | 3 | EFO_0021901 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.21e-03 | 224 | 104 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | African Burkitt's lymphoma | 1.25e-03 | 15 | 104 | 2 | C0343640 | |
| Disease | Burkitt Leukemia | 1.25e-03 | 15 | 104 | 2 | C4721444 | |
| Disease | phospholipids:total lipids ratio | 1.28e-03 | 227 | 104 | 5 | EFO_0020946 | |
| Disease | eosinophil percentage of granulocytes | 1.46e-03 | 234 | 104 | 5 | EFO_0007996 | |
| Disease | Eye Abnormalities | 1.62e-03 | 17 | 104 | 2 | C0015393 | |
| Disease | basophil count, eosinophil count | 1.66e-03 | 241 | 104 | 5 | EFO_0004842, EFO_0005090 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.72e-03 | 243 | 104 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.81e-03 | 18 | 104 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | Pancreatic carcinoma | 2.02e-03 | 19 | 104 | 2 | C0235974 | |
| Disease | intraocular pressure measurement | 2.20e-03 | 509 | 104 | 7 | EFO_0004695 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.20e-03 | 257 | 104 | 5 | DOID:10652 (is_marker_for) | |
| Disease | prostate cancer (is_marker_for) | 2.29e-03 | 156 | 104 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Non-Small Cell Lung Carcinoma | 2.29e-03 | 156 | 104 | 4 | C0007131 | |
| Disease | dilated cardiomyopathy (biomarker_via_orthology) | 2.71e-03 | 22 | 104 | 2 | DOID:12930 (biomarker_via_orthology) | |
| Disease | triacylglycerol 58:9 measurement | 2.71e-03 | 22 | 104 | 2 | EFO_0010443 | |
| Disease | transitional cell carcinoma (is_implicated_in) | 2.71e-03 | 22 | 104 | 2 | DOID:2671 (is_implicated_in) | |
| Disease | diet measurement, fasting blood insulin measurement | 2.71e-03 | 22 | 104 | 2 | EFO_0004466, EFO_0008111 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.87e-03 | 80 | 104 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | diet measurement, HOMA-IR | 2.97e-03 | 23 | 104 | 2 | EFO_0004501, EFO_0008111 | |
| Disease | Colorectal Neoplasms | 3.04e-03 | 277 | 104 | 5 | C0009404 | |
| Disease | lipoprotein measurement, phospholipid measurement | 3.41e-03 | 85 | 104 | 3 | EFO_0004639, EFO_0004732 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRNGKYVNIQEVMDQ | 576 | Q9UKU6 | |
| KLQAKQEVDNGMLYL | 581 | O14727 | |
| YSLMENGKIKVLNQE | 66 | P05090 | |
| YQNDIALIEMKKDGN | 426 | P05156 | |
| QMVESGTERYQKLQK | 131 | Q92556 | |
| KEVMKQQDVIYELIQ | 231 | Q92974 | |
| IQNLVKVYRDGMKVA | 901 | O95477 | |
| MIQIIKLDYNLNGVI | 371 | Q8N139 | |
| YIRDGIKKQQIDSIM | 156 | Q9Y2T1 | |
| INKINMKDLVVAYGT | 396 | Q96CM8 | |
| YMEGQVLHLQKQIKE | 1466 | Q96PN6 | |
| ERNMVELGQVKQYKQ | 1466 | Q9UPS8 | |
| KLNLAKTQYMDGINI | 126 | Q01459 | |
| ENEKVVLKNYQDMVV | 376 | P12643 | |
| LQVEYGKCQLQMKEL | 76 | Q9UKL3 | |
| KPLNYEEKQQMILQI | 421 | Q02487 | |
| VMVLLQEQNLGIRYK | 811 | Q9UKP5 | |
| EINNMKTELEKYGIQ | 181 | P46940 | |
| LKTNYQLGELVMVKE | 336 | Q9H2T7 | |
| YMEANKNIGKIVLEL | 316 | Q53FA7 | |
| RQTQGQKVKEYQMEL | 196 | Q92878 | |
| GVKQMYKNLDLLSQL | 406 | Q9UJ41 | |
| FNILVENKMKIYGVE | 106 | Q9Y5G8 | |
| NPLEKYMKIIQQEQD | 956 | O75665 | |
| QYLKQVLGQMVIDEE | 106 | P28070 | |
| LAGQTLKQQKYMAEQ | 976 | Q7Z5J8 | |
| EQLYEMFQNILGIKK | 271 | Q9ULU8 | |
| QIVKGLKYMLEVEIG | 81 | O76096 | |
| MIIYKQGITFLQKEN | 1 | Q8NG78 | |
| LEQLAQQGKIKEKMY | 51 | Q9P2W1 | |
| FIYEKLKAQQEMLGE | 936 | Q9UI26 | |
| NDELLQMAKQLGYKL | 176 | Q9BZQ6 | |
| LKQMLDILVYEEQQQ | 56 | Q86V87 | |
| VLQQRILEMNDKYVK | 726 | Q14149 | |
| EIDQKLQEIMKQTGY | 91 | O14733 | |
| PEEQYKVMLQVNGKE | 11 | Q76G19 | |
| LKQENKMFQDLLGEY | 586 | Q99550 | |
| VQEQQMQKLLLEYKA | 1016 | Q9UJF2 | |
| FKVEVYQQQIEMEKL | 2286 | O94854 | |
| KIAEAYQMLKKQGIV | 131 | Q9UJY5 | |
| VGQLYKEQLAKLMAT | 646 | P35579 | |
| KQYNMVDKNVIEIGA | 111 | A6NDL7 | |
| IKEQFLQQKVMVEAY | 841 | Q08378 | |
| RLELDKYIQGLKNNM | 166 | Q9HAS0 | |
| MLQQKLGELKEQYST | 3851 | Q9UPN3 | |
| MEVGIYANILEKQAK | 271 | Q7Z6M3 | |
| KIMKNAYENREVINV | 1276 | Q9P2D7 | |
| NKMEKQGDLIRYIVL | 2056 | Q13535 | |
| TLQLKEQKIMDLYGQ | 96 | Q9NZH8 | |
| EVNKLQKGIEMYNQE | 111 | Q96LB3 | |
| INLGKNYEKAVNAMI | 31 | Q9UHR4 | |
| MLLQNLGYSVDVKKN | 191 | P29466 | |
| ILLKATFKQQGVEYM | 3141 | Q8TD57 | |
| YTLGVKQLIVGVNKM | 141 | Q05639 | |
| YTLGVKQLIVGVNKM | 141 | P68104 | |
| NYVKEIENLKNELMA | 126 | Q8IWJ2 | |
| RKFGTQMYEQQVVKL | 251 | Q96C10 | |
| KEQLYEMFQQILGIK | 236 | Q86UW7 | |
| YTLGVKQLIVGVNKM | 141 | Q5VTE0 | |
| MVDKNIYIIQGEINI | 1 | Q92538 | |
| DLVVMAEQYKLNQQK | 596 | Q86TM3 | |
| KDVIINQEGEYIKMF | 216 | Q9HC35 | |
| VGYVLQNEKIQKLME | 296 | Q02742 | |
| LLKAGMTVKQAIVYN | 721 | Q9ULF5 | |
| ELKDQIQDVEGKYMQ | 141 | Q32MZ4 | |
| YKSALQVLIEMKNQD | 181 | Q8WV60 | |
| PKIVIQENRKEAQYM | 211 | O15403 | |
| QLEGLKYIERNEQKM | 731 | Q9NP80 | |
| VLKVQLKKYVGAVQM | 536 | Q8TEQ0 | |
| EVKAINIEMYQKLQG | 356 | Q8WXA3 | |
| LNAGIIKTDQNYEKM | 801 | Q9P2J5 | |
| VMFEKIAKYIGENLQ | 11 | Q9Y221 | |
| SALMVNGVLKQYQIK | 746 | P51532 | |
| QLIEFYKKENMGLVT | 81 | Q92835 | |
| LNVQMEYLLQKIQEK | 226 | Q9P031 | |
| MIQKVGQIEDFLYQL | 526 | Q9BXB7 | |
| LMLNEKEAQQVYGGK | 211 | Q9H7Z7 | |
| IQLVDVLYNEEKQKM | 111 | Q15831 | |
| VLVMYIGQVAKDVLK | 126 | Q8IWX5 | |
| MNLGLQKIFQEMLYI | 526 | Q01082 | |
| YQELKKMVQQSDLGQ | 281 | Q9H553 | |
| LLYQGMQEEQKKLIQ | 616 | Q96JN2 | |
| YDQLLKQVEALKMEN | 6 | P25054 | |
| GHLKQMEKIYTQQIQ | 116 | Q9NPC3 | |
| EGNYKTVLMLQKENL | 106 | Q9H7R5 | |
| KEFKLTVENIGYQML | 556 | Q8IWZ8 | |
| MALYLQQAKELINKV | 276 | Q9BYV2 | |
| GLKFMVYLQKENIID | 61 | A0A087X0M5 | |
| ELSQMKQELLYKEQG | 181 | Q6AWC2 | |
| QELMKIVGIKYEVGL | 1001 | Q8WWQ0 | |
| IKQYVQRQCMKLLEG | 2886 | O60673 | |
| IQQKKMAQYLTDILG | 426 | O75038 | |
| QILQGEKKAVMEQFR | 101 | P42226 | |
| YKGQKLAEQMFQGII | 81 | Q9Y6A9 | |
| LEQEKMAYQKTVEQL | 1251 | O60343 | |
| NMGKEELQKVLFEQI | 936 | Q2VWA4 | |
| KAIKRFQIMNEIVYE | 696 | O75643 | |
| VYVKGADAIKLMNIV | 181 | Q9ULT6 | |
| AMNLNLQKALEEKYG | 256 | O43247 | |
| RKVLEQLVKYMNSGN | 331 | O15050 | |
| QLQEGTLQEYQKRMK | 86 | Q9H7L9 | |
| QQKRVKEEKMYGQIV | 1456 | P31629 | |
| KKAYVEANQMLGDLI | 891 | P11498 | |
| ELTQMKQELQYKEKG | 106 | Q9ULE0 | |
| YDVMDNLLIQVTGKK | 161 | A2RUC4 | |
| VTNVMKVINKYKGNV | 956 | Q9C0D4 | |
| MKEIIDLQQYKIANN | 441 | Q9UKW4 | |
| MIKEYQEKIDVLSQQ | 621 | Q9C099 | |
| DPELIKQVVKQMFYI | 1681 | Q9Y4I1 | |
| YQVDRGNKIKLMVEI | 266 | Q14324 |